Anoro Ellipta is a brand-name inhaler that’s prescribed for long-term chronic obstructive pulmonary disease (COPD) treatment. Anoro Ellipta contains the active ingredients vilanterol and ...

The St. Helena Historical Society is hosting a “Dinner at the Museum” fundraiser at 5:30 p.m. Saturday, July 20, at the ...

Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”), a diversified holding company with a core royalties portfolio, a leading critical care and ...

Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”), a diversified holding company with a core royalties portfolio, a leading critical care and ...

Umeclidinium is a prescription antimuscarinic bronchodilator available in the form of an inhaler device. It is used to treat chronic obstructive pulmonary disease (COPD) and is available in ...

Innoviva, Inc. (NASDAQ: INVA) ("Innoviva" or the "Company"), a diversified holding company with a core royalties portfolio, a ...

Its notable products include Relvar/Breo/Ellipta and Anoro Ellipta among others, with new additions like XACDURO enhancing its market presence. The company's financial results for Q1 2024 showed a ...

The LTM global net sales for RELVAR/BREO ELLIPTA and ANORO ELLIPTA amounted to approximately $1.1 billion, indicating a strong performance in the market. Furthermore, the company's respiratory ...

GSK plc GSK reported core earnings of $1.09 per American depositary share (“ADS”) in first- quarter 2024, beating the Zacks Consensus Estimate of 94 cents. Core earnings rose 16% year over ...

“The FTC acts as if the agency is being perfectly clear on what it’s subjecting companies to, but there’s never been a conversation around what it means for a patent to claim a drug product ...